Immunologic tests and treatments in patients with unexplained infertility, IVF-ET, and recurrent pregnancy loss

Clinical Obstetrics and Gynecology

Volumn 42, Issue 4, 1999, Pages 979-1000

  Stovall, Dale W ^a,c   Van Voorhis, Bradley J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; CALCIUM; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; BLEEDING; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; LEUKOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; THROMBOCYTOPENIA; ZONA PELLUCIDA;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOTHERAPY; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT FAILURE;

EID: 0033385802     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199912000-00025     Document Type: Conference Paper

References (99)

1. Branch DW. Antiphospholipid antibodies and reproductive outcome: The current state of affairs. J Reprod Immunol. 1997; 38:75-97.
2. Kutteh WH. Antiphospholipid antibodies and reproduction. J Reprod Immunol. 1997; 35:151-171.
3. Hatasaka HH, Branch DW, Kutteh WH, Scott JR. Autoantibody screening for infertility: Explaining the unexplained? J Reprod Immunol. 1997;34:137-153.
4. Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol. 1997;89:549-555.
5. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril. 1996;66:540-546.
6. Bahar AM, Kwak JYH, Beer AE, et al. Antibodies to phospholipids and nuclear antigens in nonpregnant women with unexplained spontaneous abortions. J Reprod Immunol. 1993;24:213-222.
7. Kwak JYH, Gilman-Sachs A, Beaman KD, Beer AE. Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology. J Reprod Immunol. 1992;22:15-31.
8. Ruiz JE, Cubillos J, Mendoze JC, Espinel FJ, Kwak JYH, Beer AE. Autoantibodies to phospholipids and nuclear antigens in nonpregnant and pregnant Colombian women with recurrent spontaneous abortions. J Reprod Immunol. 1995;28:41-51.
9. Silver RM, Porter TF, Van Leeuween I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clinical consequences of low titers. Obstet Gynecol. 1996;87:494-500.
10. Peaceman AM, Silver RK, MacGregor SN, Socol ML. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol. 1992;166:1780-1787.
11. Cowchock S, Smith JB, Gocial S. Antibodies to phospholipids and nuclear antigens in patients with related abortions. Am J Obstet Gynecol. 1986;155:1002-1010.
12. Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum. 1987;30:601-606.
13. Bussen S, Steck T. Thyroid autoantibodies in euthyroid nonpregnant women with recurrent spontaneous abortions. Hum Reprod. 1995;10:2938-2940.
14. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies in recurrent pregnancy loss. Am J Obstet Gynecol. 1993;168:837-841.
15. Stirrat GM. Recurrent miscarriage II: Clinical associations, causes, and management. Lancet. 1990;336:728-733.
16. Gleicher N, El-Roeiy A, Confine E, Friberg J. Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol. 1989;160:1376-1385.
17. Wilson C, Bade OE, Elstein M, Lloyd R, Wright R. Smooth-muscle antibodies in infertility. Lancet. 1975;December:1238-1239.
18. Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol. 1989;161:377-379.
19. Roussev RG, Kaider BD, Price DE, Coulam CB. Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol. 1996;35:415-420.
20. Geva E, Vardinon N, Yaron Y, Burke M, Lessing JB, Amit A, Yovel I. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril. 1994;62:802-806.
21. Geva E, Amit A, Lerner-Geva L, Azem F, Yovel I, Lessing JB. Autoimmune disorders: Another possible cause for in vitro fertilization and embryo transfer failure. Hum Reprod. 1995;10:2560-2563.
22. Nip MMC, Taylor PV, Rutherford AJ, Hancock KW. Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients: Relation to reproductive outcome after in vitro fertilization. Hum Reprod. 1995;10:2564-2569.
23. Fisch B, Tadir Y, Rikover Y, et al. The relationship between in vitro fertilization and naturally occurring antibodies: Evidence for increased production of antiphospholipid autoantibodies. Fertil Steril. 1991; 56:718-724.
24. Birkenfeld A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemni M. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol. 1994;31:65-68.
25. Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW. Antiphospholipid antibodies in women having in vitro fertilization. Hum Reprod. 1996;11:1185-1189.
26. Kutteh WH, Yetman DL, Chantilis SJ, Byrd W, Crain J, Murty GS. (1996) Increased occurrence of early pregnancy loss associated with the presence of anticardiolipin antibodies (ACA) in women undergoing IVF. Abstract #O-131, American Society for Reproductive Medicine Annual Meeting; November 2-7, 1996; Boston.
27. Schenk LM, Butler L, Monis JP, et al. (1996) Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. Abstract O-076, American Society for Reproductive Medicine Annual Meeting; November 2-7, 1996; Boston.
28. El-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol. 1987;70:163-170.
29. Sher G, Feinman M, Zouves C, et al. High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod. 1994;9:2278-2283.
30. Kowalik A, Vichnin M, Branch W, Berkely A. (1996) Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with IVF outcome. Abstract P-130, American Society for Reproductive Medicine Annual Meeting; November 2-7, 1996; Boston.
31. Gleicher N, Liu H-C, Dudkiewicz A, et al. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol. 1994;170: 1145-1149.
32. Mathur S, Peress MR, Williamsom HO, et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol. 1982;50:259-266.
33. Wild RS, Shivers CA. Antiendometrial antibodies in patients with endometriosis. Am J Reprod Immunol Microbiol. 1985;8: 84-86.
34. Wild RA, Satyaswaroop PG, Shivers AC. Epithelial localization of antiendometrial antibodies associated with endometriosis. Am J Reprod Immunol Microbiol. 1987;13: 62-65.
35. Wild RA, Podczaski ES, Hirisave V, et al. Endometrial antibodies versus CA-125 for the detection of endometriosis. Fertil Steril. 1991;55:90-94.
36. Wild RA, Hirisave V, Podczaski ES, et al. Autoantibodies associated with endometriosis: Can their detection predict presence of the disease? Obstet Gynaecol. 1991;77: 927-931.
37. Badawy SZA, Cuenca V, Freliech H, Stefanu C. Endometrial antibodies in serum and peritoneal fluid of infertile patients with and without endometriosis. Fertil Steril. 1990;53:930-932.
38. Kennedy SH, Starkey PM, Sargent IL, et al. Localization of anti-endometrial antibody binding in women with endometriosis using a double-labelling immunohistochemical method. Br J Obstet Gynaecol. 1990;97: 671-674.
39. Kennedy SH, Starkey PM, Sargent IL, et al. Anti-endometrial antibodies in endometriosis measured by an enzyme-linked immunoabsorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol. 1990;75:914-918.
40. Switchenko AC, Kauffman RS, Becker M. Are there antiendometrial antibodies in sera of women with endometriosis? Fertil Steril. 1991;56:235-241.
41. Fernandez-Shaw S, Hicks BR, Yudkin PL, et al. Anti-endometrial and anti-endothelial autoantibodies in women with endometriosis. Hum Reprod. 1993;8:310-315.
42. Fernandez-Shaw S, Kennedy SH, Hicks BR, Edmonds K, Starkey PM, Barlow DH. Antiendometrial antibodies in women measured by an enzyme-linked immunosorbent assay. Hum Reprod. 1996;11:1180-1184.
43. Odukoya OA, Wheatcroft N, Weetman AP, Cooke ID. The prevalence of endometrial immunoglobulin G antibodies in patients with endometriosis. Hum Reprod. 1995;10: 1214-1219.
44. Kim JG, Kim CW, Moon SY, Chang YS, Lee JY. Detections of antiendometrial antibodies in sera of patients with endometriosis by dual-colored, double-labeling immunohistochemical method and western blot. Am J Reprod Immunol. 1995;34:80-87,
45. Gorai I, Ishikawa M, Onose R, Hirahara F, Minaguchi H. Antiendometrial autoantibodies are generated in patients with endometriosis. Am J Reprod Immunol. 1993;29: 116-123.
46. Gleicher N, El-Roeiy A, Confino E, Friberg J. (1987) Is endometriosis an autoimmune disease? Obstet Gynecol. 1987;70:115-122.
47. Kilpatrick DC, Haining R, Smith S. Are cardiolipin levels elevated in endometriosis? Fertil Steril. 1991;55:436-437.
48. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211-1214.
49. Kennedy SH, Nunn B, Phil D, Cederholm-Williams SA, Phil D, Barlow DH. (1989) Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus. Fertil Steril. 1989;52:1061-1062.
50. Taylor PV, Maloney MD, Campbell JM, et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol. 1991;98: 680-684.
51. Shivers CA, Dunbar BS Autoantibodies to zona pellucida: A possible cause for infertility in women. Science. 1977;197:1082-1084.
52. Sacco AG, Moghissi KS. Antizona pellucida activity in human sera. Fertil Steril. 1979;31:503-506.
53. Mon T, Nishimoto T, Kitagawa M, Noda Y, Nishimura T, Oikawa T. Possible presence of autoantibodies to zona pellucida in infertile women. Experientia. 1977;34:797-799.
54. Mori T, Nishimoto T, Kohda H, Takai I, Nishimura T, Oikawa T. A method for specific detection of autoantibodies to the zona pellucida in infertile women. Fertil Steril. 1979;32:67-72.
55. Mori T, Kamada M, Yamano S, Kinoshita T, Kano K, Mori T. Production of monoclonal antibodies to porcine zona pellucida and their inhibition of sperm penetration through human zona pellucida in vitro. J Reprod Immunol. 1985;8:1-11.
56. Buckshee K, Mhaskar A. Status of autoantibodies to zona pellucida in human reproduction. Int J Fertil. 1985;30:13-17.
57. Nayudu PL, Freemann LE, Trounson AO. Zona pellucida antibodies in human sera. J Reprod Fertil. 1982;65:77-84.
58. Kamada M, Hasebe H, Irahara M, Kinoshita T, Naka O, Mori T. Detection of antizona pellucida activities in human sera by the passive hemagglutination reaction. Fertil Steril. 1984;41:901-906.
59. Kamada M, Daitoh T, Mori K, et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol. 1992;28:104-109.
60. Caudle MR, Shivers CA, Wild RA. Clinical significance of naturally occurring antizona pellucida antibodies in infertile women. Am J Reprod Immunol. Microbiology. 1987;15:119-121.
61. Papale ML, Grillo A, Leonardi E, Giuffrida G, Palumbo M. Palumbo G. Assessment of the relevance of zona pellucida antibodies in follicular fluid of in vitro fertilization (IVF) patients. Hum Reprod. 1994;9:1827-1831.
62. Hovav Y, Almagor M, Benbenishti D, Margalioth EJ, Kafka I. Yaffe H. Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts. Hum Reprod. 1994;9:643-645.
63. Curtis P, Keith E, Burford G, Shaw RW, Amso N. Assessment of the relevance of zona pellucida antibodies in serum and cervical mucus in patients who have fertilization failure during in vitro fertilization. Fertil Steril. 1991;56:1124-1127.
64. Kurachi H, Wakimoto H, Sakumoto T, Aono T, Kurachi K. Specific antibodies to porcine zona pellucida detected by quantitative radioimmunoassay in both fertile and infertile women. Fertil Steril. 1984;41:265-269.
65. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden R. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Human Reprod. 1994;9:1954-1957.
66. Hauth JC, Goldenberg RL, Parker CR, Cutter GR, Cliver SP. Low-dose aspirin: Lack of an association with an increase in abruptio placenta or perinatal mortality. Obstet Gynecol. 1995;85:1055-1058.
67. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol. 1989;20:52-67.
68. Chamley LW, McKay EJ, Pattison MS. Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosis. Thromb Res. 1993;71:103-111.
69. Shibata S, Harpel P, Bona C, Filit H. Monoclonal antibodies to heparin sulfate inhibit the formation of thrombin-anti-thrombin III complexes. Clin Immunol Immunopathol. 1993;67:264-272.
70. Ermel LD, Marshburn PB, Kutteh WH. Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol. 1995;33:14-20.
71. McIntyre JA, Taylor CG, Torry DS, Wagenknecht DR, Wilson J, Faulk WP. Heparin and pregnancy in women with a history of repeated miscarriages. Haemostasis. 1993;23(suppl 1):202-211.
72. Dahlman T, Sjoberg HE, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol. 1994;170:1315-1320.
73. Pountain GD, Keogan MT, Hazleman BL, Brown DL. Effects of single dose compared with three days prednisolone treatment of health volunteers: Contrasting effects on circulating lymphocyte subsets. , J Clin Pathol. 1993;46:1089-1092.
74. Lachapelle MH, Miron P, Hemmigs R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol. 1996;156:4027-4034.
75. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992; 155:1318-1323.
76. ASHP Commission on Therapeutics. ASHP therapeutic guidelines for intravenous immune globulin. Clin Pharm. 1992; 11:117-136.
77. Arnout J, Spitz B, Wittevrongel C, Vanrusselt M, Van Assche A, Vermylen J. Highdose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: Immunological changes associated with a successful outcome. Thromb Haemost. 1994;71:741-747.
78. Anderson CL. Human IgG fc receptors. Clin Immunol Immunopathol. 1989;53: 563-571.
79. Arvieux J, Roussel B, Pouzol P, Columb MG. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I. Thromb Haemost. 1993;70:336-341.
80. Arnout J. The pathogenesis of the antiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost. 1996;75: 536-541.
81. The Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide Collaborative Observational Study and Meta-Analysis on Allogenic Leukocyte Immunotherapy for Recurrent Spontaneous Abortion. Am J Reprod Immunol. 1994;32:55-72.
82. Hasegawa I, Yamanoto Y, Suzuki M, et al. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril. 1998; 70:1044-1048.
83. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect on antiphospholipid antibodies in women undergoing in vitro fertilization: Role of heparin and aspirin. Human Reprod. 1997;12:1171-1175.
84. Lubbe WF, Palmer SJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet. 1983;1:1361-1363.
85. Mowbray JF, Liddel H, Underwood JL, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet. 1985;1:941-943.
86. Ho H-N, Gill TJ, Hsieh HE, et al. Immunotherapy for recurrent spontaneous abortions in a Chinese population. Am J Reprod Immunol. 1991;25:10-15.
87. Cauchi MN, Lim D, Young DE, et al. Treatment of recurrent aborters by immunization with paternal cells in a controlled trial. Am J Reprod Immunol. 1991;25:16-17.
88. Gatenby PA, Cameron K, Simes RJ, et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: Results of a controlled trial. Am J Reprod Immunol. 1993;29:88-94.
89. Cowchock FS, Reece EA, Balban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166:1318-1323.
90. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584-1589.
91. Laskin C, Bombardier C, Mandel F, et al. A randomized controlled trial of prednisone and ASA in women with autoantibodies and unexplained recurrent fetal loss. Presented at the Society of Perinatal Obstetricians Meeting, Kamuela, Hawaii, February 5-10, 1996.
92. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol. 1996;35:402-407.
93. The German RSA/IVIG Group: Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynecol. 1994;101:1072-1077.
94. Coulam CB, Krysa L, Stern JJ, et al. Intravenous immunoglobulin for the treatment of recurrent pregnancy loss. Am J Reprod Immunol. 1995;34:333-337.
95. Christiansen OB, Mathiesen O, Husth M, et al. Placebo-controlled trial of treatment of unexplained secondary spontaneous abortions and recurrent late spontaneous abortions with IV immunoglobulin. Human Reprod. 1995;10:2690-2695.
96. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol. 1989;161:1271-1272.
97. Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol. 1995; 172:690-694.
98. Valensise H, Vaquero E, De Carolis C, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenat Diagn. 1995;15:509-517.
99. Clark AL, Branch DW, Silver RM, Harris EN, Pierangeli S, Spinnato JA. Pregnancy complicated by the Antiphospholipid Syndrome: Outcomes with intravenous immunoglobulin therapy. Obstet Gynecol. 1999; 93:437-441.